PJPvsGNMXETF Comparison
VS
Invesco Dynamic Pharmaceuticals ETF (PJP) belongs to the US Health Care segment. Corgi Genomics & Precision Medicine ETF (GNMX) is part of the BioTech & Genomics segment. Both ETFs have the same top 1 sector exposures: Healthcare. PJP is more expensive with a Total Expense Ratio (TER) of 0.58%, versus 0.35% for GNMX. Run a side-by-side ETF comparison of PJP and GNMX below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PJP vs GNMX performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/14/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PJP GNMX | -0.27%+8.66% | +10.81%+28.58% | +20.18%n/a | +38.79%n/a | +67.59%n/a | +66.54%n/a |
| Flows | PJP GNMX | +$36M+$1M | +$158M+$761K | +$166M- | +$180M- | +$114M- | -$33M- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PJP GNMX | +18.23%+33.26% | +17.04%n/a | +16.36%n/a | +16.47%n/a |
| Max drawdown | PJP GNMX | -5.67%-8.53% | -9.42%n/a | -16.11%n/a | -17.41%n/a |
| Max drawdown duration | PJP GNMX | 26d32d | 108dn/a | 275dn/a | 788dn/a |
Trading data
PJP | GNMX | |
Last sale 9/15/2026 at 2:10 PM | $123.43 | |
| Previous close 09/14/2026 | $124.96 | |
| Consolidated volume 09/14/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
GNMX
is actively managed and doesn’t replicate an indexPJP | GNMX | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/15/2026 at 2:10 PM
Live
Closed
PJP | GNMX | |
|---|---|---|
| Last price | $123.43 | – |
| 1D performance | -1.22% | – |
| AuM | $547.22 M | $2.60 M |
| E/R | 0.58% | 0.35% |
Characteristics
PJP | GNMX | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Invesco | Corgi Funds |
| Benchmark | Dynamic Pharmaceutical Intellidex Index | - |
| N° of holdings | 28 | 57 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 23, 2005 | May 6, 2026 |
| ESG | No | No |
Advertisement
Exposure
Countries
PJP
USA
94.69%
Other
5.31%
GNMX
USA
87.58%
Other
12.42%
Sectors
PJP
Healthcare
100%
Other
-0%
GNMX
Healthcare
96.78%
Other
3.22%
Diversification
PJP
Total weight of top 15 holdings out of 15
65.5%
GNMX
Total weight of top 15 holdings out of 15
55.56%
Top 15 holdings
Data as of July 31, 2026
PJP
Abbott Laboratories
5.76%
AbbVie, Inc.
5.71%
Amgen, Inc.
5.33%
Johnson & Johnson
5.33%
Eli Lilly & Co.
5.25%
Merck & Co., Inc.
5.03%
Gilead Sciences, Inc.
4.58%
Pfizer Inc.
4.49%
Corcept Therapeutics, Inc.
4.00%
Amneal Pharmaceuticals, Inc.
3.88%
Liquidia Corp.
3.75%
Travere Therapeutics, Inc.
3.26%
Ligand Pharmaceuticals, Inc.
3.18%
Harmony Biosciences Holdings, Inc.
3.10%
Viatris, Inc.
2.85%
GNMX
Thermo Fisher Scientific, Inc.
9.28%
Vertex Pharmaceuticals, Inc.
6.75%
Illumina, Inc.
4.56%
Guardant Health, Inc.
4.26%
Revolution Medicines, Inc.
3.92%
Incyte Corp.
3.38%
Moderna, Inc.
3.06%
Genmab A/S
2.96%
Alnylam Pharmaceuticals, Inc.
2.77%
Bio-Techne Corp.
2.67%
10X Genomics, Inc.
2.58%
BioMarin Pharmaceutical, Inc.
2.55%
Arrowhead Pharmaceuticals, Inc.
2.34%
Krystal Biotech, Inc.
2.30%
QIAGEN NV
2.18%
Frequently asked questions about PJP and GNMX
